Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
Annals of Neurology|December 15, 2015
MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signsObaid M Albulym, Marina L Kennerson, Matthew B Harms, et al.Muscle & Nerve|January 4, 2020
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALSNamita A Goyal, James D Berry, Anthony Windebank, et al.Immunity|October 28, 2018
T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell DifferentiationKenichi Shimada, Rebecca A Porritt, Janet L Markman, et al.JAMA Neurology|February 19, 2014
TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosisJanet Cady, Erica D Koval, Bruno A Benitez, et al.Nature|August 21, 2020
C9orf72 in myeloid cells suppresses STING-induced inflammationMadelyn E McCauley, Jacqueline Gire O'Rourke, Alberto Yáñez, et al.Science (New York, N.Y.)|April 21, 2018
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2AAgostinho G Rocha, Antonietta Franco, Andrzej M Krezel, et al.Muscle & Nerve|May 24, 2020
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunitiesJinsy A Andrews, James D Berry, Robert H Baloh, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.Neurobiology of Disease|June 8, 2013
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with ageJudith Eschbach, Jérôme Sinniger, Jamal Bouitbir, et al.Stem Cells Translational Medicine|January 29, 2021
Neural crest-derived mesenchymal progenitor cells enhance cranial allograft integrationJuliane D Glaeser, Phillip Behrens, Tina Stefanovic, et al.Pageof 9